You are here

Article info

Article menu
Download PDFPDF
Correspondence response
Response to: 'Is it time to redefine the role of low-dose radiotherapy for benign disease?' by Montero et al

Authors

  1. Correspondence to Elien A M Mahler, Department of Rheumatology, Sint Maartenskliniek, Nijmegen 6500 GM, The Netherlands; e.mahler{at}maartenskliniek.nl
View Full Text

Citation

Mahler EAM, Minten MJ, Leseman-Hoogenboom MM, et al
Response to: 'Is it time to redefine the role of low-dose radiotherapy for benign disease?' by Montero et al
Annals of the Rheumatic Diseases 2020;79:e35.

Publication history

  • Received January 13, 2019
  • Accepted January 20, 2019
  • First published February 1, 2019.
Online issue publication 
May 12, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.